ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Arizona Cancer Center Seeks NCI Recognition As Comprehensive

May 29, 1987

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

September 25, 1998

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993